The microarray market size is projected to reach a revenue of US$ 8.15 billion by 2030 and is expected to register a CAGR of 8.2% from 2021 to 2030, According to Precedence Research. The research report contains 150+ pages with detailed analysis. Growing incidence of cancer worldwide and developments in bioinformatics are main factors driving the microarray market.
The report provides the overall revenue of the global microarray market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year. This research report evaluates the microarray market on a global and regional level.
A microarray can be described as a semiconductor covering on which arrangements of many wide-ranging genes are attached to probes. Microarrays are employed to measure expression levels of quantity of genes instantaneously or to genotype several areas of a genome. The method finds application in clinical diagnosis, drug R&D, environment control, and agriculture among other sectors. The microarrays have a wide range of usage and are finding applications in toxicological response outlining, basic molecular biology, biomarker recognition, and pharmaceutical target evaluation. The capability of microarrays to enable analysis of several thousands of genes at the equivalent time has led to the success of this novel technology. Numerous other factors like global upsurge in the prevalence of cancer is also one of the significant factors which are encouraging market growth to greater level.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1201
The microarray market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This research report offers scenarios and forecasts (revenue/volume) and categorizes the market by players, type, application, and region. This report also studies global market prominence, competitive landscape, market share, growth rates market dynamics such as drivers, restraints and opportunities, and distributors and sales channels.
This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.
Factors such as growing incidence of cancer worldwide, increasing expenditure on research and development in the healthcare sector, growing number of applications of microarrays, advances in the fields of proteomics and genomics, developments in bioinformatics, evolution of software’s, growing awareness regarding personalized medicines, and increasing preference for DNA based microarrays are driving the growth of microarray market. Moreover, growing applications of microarrays in the diagnosis of infectious and genetic diseases, drug discovery, and pharmacogenomics research, among others is driving the microarray market growth across the world. Additional features that are expected to fuel this business is increasing requirement for new investigative approaches and technological innovation.
Cancer has a significant impact on people across the world. Growing occurrences of cancer is amongst the key aspects driving market evolution. As per WHO(World Health Organization), the United States is anticipated to witness high volume of fresh cancer cases and is projected to rise about 24% in men to higher than 1 million cases each year, and by around 21% in women to greater than 900,000 cases each year, from 2010 to 2022. Microarray is one of the techniques that are used by scientists to overcome the restriction of traditional mechanism. Researchers can examine the expression of several genes simultaneously and competently by employing microarrays. This procedure helps in early recognition of cancer. The usage of NGS (Next-Generation Sequencing) and microarrays and has presented noteworthy contributions with the purpose of understanding the progress of cancer.
Among the product segment, consumables dominated the overall market in 2020. Recurrence and bulk procurement of consumables for numerous research applications is the foremost factor attributing to its large market share.
The DNA microarrays accounted for the major share of revenue in the type segment with more than 51% share in 2020 due to its wide array of applications in the area of gene expression investigation, genotyping, and transcription factor binding investigation amid others. Protein microarrays are anticipated to grow at the uppermost CAGR through the forecast duration.
Research Applications accounted for the largest revenue. Widespread availability of tablets is the key reason for high market share. Growth in government along with private funding for study in proteomics and genomics is the key reason for foremost market share of research applications.
Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., accounted for a significant share of the global microarray market.
The report includes information for Asia Pacific, North America, Latin America, Europe, Middle East, and Africa. In 2020, the North American region dominated the worldwide market with a market share of higher than 39%. The United States indicated the highest slice in North America principally due to heavy expenditure in microarray research and development and existence of skilled scientists. Moreover, early execution of latest healthcare technologies also supported the high market portion of the United States.
Europe was the subsequent significant market chiefly due to presence of key manufacturers. Growing focus on personalized medicines in the European region is also expected to boost the demand for microarray in the anticipated time-span. The Asia Pacific region is projected to grow at the highest CAGR of around8.9% in the estimate period due to high prevalence of cancer. Africa, Middle East, and Latin American region will display noticeable growth.
Key Market Players and Strategies:
The key companies functioning in the worldwide microarray market are Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Merck & Co., Inc., PerkinElmer, Inc., Arrayit Corporation, Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, and Affymetrix among others.
Increased spending on research and development along with mergers, acquisition, and collaborations are the important strategies taken up by manufacturers operational in the global microarray market. Moreover, leading companies are investing heavily on research for the development for the development of new diagnostic methods. As per an investigative study broadcasted in 2019 by the Royal Chemistry Society, a moveable fluorescence microarray imaging structure that links to a smartphone has been employed for the recognition of breast cancer gene expression.
Software & Services
By End User
Research & Academic Institutes
Pharmaceutical & Biotechnology Companies
Other End Users
North America (U.S. and Canada)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
Latin America (Brazil and Rest of Latin America)
Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Why should you invest in this report?
If you are aiming to enter the global microarray market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for microarray are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4999) @ https://www.precedenceresearch.com/checkout/1201
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.
Call: +1 9197 992 333